Moody’s Investors Service has projected that India will be witnessing a GDP growth rate of 9.3 per cent and 7.9 per cent in FY22 and FY23 respectively.
Moody’s analyst Sweta Patodia has claimed that steady progress in vaccination against Covid-19 will bring about a sustained recovery in the economic activity of the country.
“Consumer demand, spending and manufacturing activity are recovering following the easing of pandemic restrictions,” Patodia was quoted in a report by Economic Times.
She added, “These trends, including high commodity prices, will propel significant growth in rated companies’ EBITDA over the next 12-18 months.”
Improved vaccination coverage has apparently led to stabalisation in consumer confidence. Along with that, India’s insistence on domestic manufacturing and amiable conditions for funding are projected to support the new investments.
The Reserve Bank of India (RBI) has maintained an accommodative stance throughout whilst also ensuring record low interest rates. Moody’s believes that these low rates will be cutting down the funding costs as companies will be refinancing higher-cost debt.
It will also make way for new capital investment, in lines with growing demand, though higher inflation continues to remain a threat.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.